American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws

J Oral Maxillofac Surg. 2007 Mar;65(3):369-76. doi: 10.1016/j.joms.2006.11.003.
No abstract available

MeSH terms

  • Administration, Oral
  • Bone Density Conservation Agents / administration & dosage
  • Bone Density Conservation Agents / adverse effects*
  • Consensus
  • Diphosphonates / administration & dosage
  • Diphosphonates / adverse effects*
  • Humans
  • Incidence
  • Injections, Intravenous
  • Jaw Diseases / chemically induced*
  • Jaw Diseases / epidemiology
  • Jaw Diseases / pathology
  • Jaw Diseases / prevention & control
  • Oral Surgical Procedures / statistics & numerical data
  • Osteonecrosis / chemically induced*
  • Osteonecrosis / epidemiology
  • Osteonecrosis / pathology
  • Osteonecrosis / prevention & control
  • Risk Assessment
  • Risk Factors
  • Societies, Dental*
  • United States / epidemiology

Substances

  • Bone Density Conservation Agents
  • Diphosphonates